Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 08:35 am Sale |
2025-03-31 | 13G | Regulus Therapeutics Inc. RGLS |
Vivo Opportunity Fund Holdings, L.P. | 2,696,426 3.900% |
-2,303,574 (-46.07%) |
Filing |
| 2024-03-20 4:30 pm Purchase |
2024-03-14 | 13G | Regulus Therapeutics Inc. RGLS |
Vivo Opportunity Fund Holdings, L.P. | 5,000,000 7.700% |
5,000,000 (New Position) |
Filing |